Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Fatty Acids and Cardiometabolic Health / Matti Marklund, Jason Wu
| Fatty Acids and Cardiometabolic Health / Matti Marklund, Jason Wu |
| Autore | Marklund Matti |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (202 p.) |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
coronary artery disease
n-6 fatty acids ischemic heart disease n-3 fatty acids body weight alternatively activated macrophages type 2 cytokines children medium-chain triglyceride fat omega-3 PUFA substitution models obesity EETs arachidonic acid blood pressure Genome-wide association study (GWAS) antioxidant Mediterranean diet Insulin sensitivity PUFA n-3 PUFA long-chain triglyceride fish oil omega 3 CAD adipose tissue FADS blood lipids hemodynamics genotype erucic acid klotho CYP450 eicosanoids cardiometabolic disease fibrosis desaturase EEQs cohort study lipid metabolism fatty acid metabolic disease epidemiology omega-3 inflammation docosapentaenoic acid omega-6 PUFA type 2 diabetes mellitus diet CKD human perivascular adipose tissue seafood cardiovascular disease prospective cohort study linoleic acid low-fat diet conjugated fatty acids furan fatty acids unsaturated fat statins fish cholesterol ester CHD COPD |
| ISBN |
9783038978916
3038978914 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910346838103321 |
Marklund Matti
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular Basis of Cardiovascular Diseases : : Implications of Natriuretic Peptides / / Speranza Rubattu, Massimo Volpe
| Molecular Basis of Cardiovascular Diseases : : Implications of Natriuretic Peptides / / Speranza Rubattu, Massimo Volpe |
| Autore | Rubattu Speranza |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (212 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
postmortem biochemistry
medulla animal models remodeling BNP PCSK9 guanylyl cyclase/natriuretic peptide receptor-A cardiorenal syndrome forensic medicine preserved ejection fraction kidney renin-angiotensin-aldosterone system atrial fibrillation vasopressor congestive heart failure atrial natriuretic peptide gene-knockout obesity heart failure angiogenesis adipose tissue vascular LDL receptor metabolic syndrome linkage analysis cardiometabolic disease cardiomyocyte cardiac dysfunction cardiac hypertrophy insulin lipid metabolism cGMP Idiopathic Pulmonary Arterial Hypertension (IPAH) Natriuretic Peptide Clearance Receptor (NPR-C) signaling gene-duplication renin–angiotensin system natriuretic peptides angiotensin receptor–neprilysin inhibitor cardiac remodelling ARNi NT-proBNP inflammation pulmonary arterial hypertension vascular homeostasis endothelial cell Atrial Natriuretic peptide natriuretic peptide vasodilator stroke genetic variants arterial hypertension fibroblast MANP hypertension guanylyl cyclase receptor A |
| ISBN |
9783039215836
3039215833 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367751403321 |
|
Rubattu Speranza
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Biomarkers for Heart Disease
| Novel Biomarkers for Heart Disease |
| Autore | Lichtenauer Michael |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (420 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
acute kidney injury
acute myocardial infarction AMI aneurysm aortic disease aortic regurgitation atrial fibrillation atrial myopathy biomarker biomarkers carbohydrate antigen-125 cardiac biomarkers cardiac intensive care units cardiac magnetic resonance imaging cardiometabolic disease cardiometabolic risks cardiovascular death cardiovascular diseases cardiovascular events cardiovascular risk cardiovascular surgery catestatin cell adhesion molecule ceramides ceruloplasmin chronic heart failure chronic kidney disease circulating cells circulating miRNAs CKD cohort studies coronary artery disease CVD diet quality echocardiography ejection fraction epicardial adipose tissue epicardial fat epicardial fat volume FABP3 fatty acid-binding protein 3 Framingham risk score GDF-15 GDF8 growth differentiation factor 15 (GDF-15) H-FABP healthy eating index heart failure heart failure decompensation heart-type fatty acid-binding protein heart-type fatty acid-binding protein (H-FABP) herat failure HF HFpEF HFrEF hypertension inflammatory marker KLF4 left ventricular adverse remodelling left ventricular ejection fraction left ventricular systolic function liver-type fatty-acid-binding protein long-term outcomes longitudinal strain magnetic resonance imaging magnetic resonance spectroscopy metabolic syndrome microRNA miRNA mitochondrial DNA (mtDNA) mitochondrial dysfunction muscle wasting myocardial infarction myocardial triglyceride content myostatin n/a NAFLD NAFLD fibrosis score NT-proBNP NYHA functional class obesity older women operative risk oxidative stress PBMCS Pentraxin-3 platelets PPCI pregnancy-associated plasma protein-A primary prevention reactive oxygen species (ROS) renal dysfunction repeated measurements risk prediction risk stratification saliva salivary biomarkers sarcopenia secondary prevention SOCE soluble suppression of tumorigenicity 2 (sST2) soluble urokinase-type plasminogen activator receptor (suPAR) sST2 STEMI STIM1 sudden cardiac death suPAR synthetic phenotype T1 mapping TGF-β pathway thyroid-stimulating hormone troponin vena contracta area ventricular arrhythmia ventricular tachycardia very low-density lipoprotein |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557546203321 |
|
Lichtenauer Michael
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pathophysiology of Spinal Cord Injury (SCI)
| Pathophysiology of Spinal Cord Injury (SCI) |
| Autore | Geoffroy Cédric |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (258 p.) |
| Soggetto topico |
Medicine
Neurosciences |
| Soggetto non controllato |
micturition
external urethral sphincter spinal cord injury serotonin electromyogram fecal microbiota transplant inflammation anxiety rehabilitation autonomic dysreflexia immune dysfunction SCI-IDS primary afferents nociceptor reach-to-grasp forelimb function upper extremity function cardiovascular contusion neuroplasticity osteopenia bone loss recovery of function monoamines GABA neuromodulation pain spasticity ionic plasticity repetitive transcranial magnetic stimulation phrenic motor network motoneuron excitability diaphragm muscle spinal cord injury severity cardiometabolic disease liver and cardiac dysfunctions fibrosis pathophysiology oxidative stress contusion model respiratory function diaphragmatic activity phrenic motoneurons neuroinflammation cytokines tumor necrosis factor immune cells microglia |
| ISBN | 3-0365-5887-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Pathophysiology of Spinal Cord Injury |
| Record Nr. | UNINA-9910639998103321 |
|
Geoffroy Cédric
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||